ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

FOCALIN XR
ADHD
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

FOCALIN XR CII

Generic Name and Formulations:
Dexmethylphenidate HCl (single-isomer methylphenidate) 5mg, 10mg, 15mg, 20mg, 25mg, 30mg, 35mg, 40mg; ext-rel caps (contains immediate-release + e-c del-rel beads).

Company:
Novartis Pharmaceuticals Corp

e-Prescribe this drug via Surescripts


Therapeutic Use:

Indications for FOCALIN XR:

Attention deficit hyperactivity disorder.

Adult Dose for FOCALIN XR:

Take once daily in the AM. Swallow whole or sprinkle contents onto applesauce (swallow immediately); do not crush, chew or divide beads. Initially 10mg/day; may increase by 10mg weekly. Usual dose: 20–40mg/day. Doses >40mg/day: not recommended. Switching from racemic methylphenidate: give ½ of total daily racemic methylphenidate dose. Switching from immediate-release dexmethylphenidate: give same total daily dose.

Children's Dose for FOCALIN XR:

Take once daily in the AM. Swallow whole or sprinkle contents onto applesauce (swallow immediately); do not crush, chew or divide beads. <6yrs: not established. Individualize. ≥6yrs: initially 5mg/day; may increase by 5mg weekly. Usual dose: 10–30mg/day. Doses >30mg/day: not recommended. Switching from racemic methylphenidate: give ½ of total daily racemic methylphenidate dose. Switching from immediate-release dexmethylphenidate: give same total daily dose.

See Also:

FOCALIN

Pharmacological Class:

CNS stimulant.

Contraindications:

Marked anxiety, tension, agitation. Glaucoma. History of tics or Tourette's syndrome in patient or family. During or within 14 days of MAOIs.

Warnings/Precautions:

History of drug dependence or alcoholism; monitor for abnormal behavior. Structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, coronary artery disease: not recommended. Hypertension. Heart failure. Recent MI. Ventricular arrhythmia. Assess cardiovascular status prior to treatment. Psychotic disorders. Bipolar disorder. Depression. Seizure disorders; discontinue if occur. Peripheral vasculopathy, including Raynaud's Phenomenon; monitor for digital changes. Reduce dose or discontinue if paradoxical aggravation of symptoms occur. Reevaluate periodically. Monitor for worsening of aggressive behavior or hostility. Monitor growth, blood pressure, heart rate, CBC, differential, platelet counts, vision. Pregnancy (Cat.C). Nursing mothers.

Interactions:

See Contraindications. Hypertensive crisis with MAOIs. Caution with pressor agents. May potentiate coumarin anticoagulants, anticonvulsants (eg, phenobarbital, phenytoin, primidone), tricyclics (eg, imipramine, clomipramine, desipramine), SSRIs; adjust doses. May decrease effectiveness of antihypertensive agents. Caps: may be affected by drugs that affect pH (eg, antacids, acid suppressants).

Adverse Reactions:

Dyspepsia, dry mouth, decreased appetite, headache, anxiety, anorexia, insomnia, nausea, abdominal pain, weight loss; hypertension, tachycardia, visual disturbances, tics.

Metabolism:

Hepatic.

Elimination:

Renal.

Generic Availability:

XR (NO); tabs (YES)

How Supplied:

XR caps, tabs—100

Sign Up for Free e-newsletters